Intas to make drug for Aussie firm

By siliconindia   |   Monday, 20 September 2004, 07:00 Hrs
Printer Print Email Email
MELBOURNE: Australian injectable generic drugs maker Mayne Group has lined up Indian drug maker Intas Pharmaceuticals to manufacture one of Mayne's major cytotoxic products in a move to control costs.

Mayne, which has a range of drugs for treating cancer, also said it was pursuing other deals in India and was opening an office in Mumbai to manage quality, manufacturing and other activities.

"As a result of this agreement, Mayne will now have access to contract manufacturing in a patent-friendly, low-cost environment, ensuring Mayne can capitalise on its global sales and marketing presence to access all international markets in a timely and cost-effective manner," the company said.

Ahmedabad-based Intas specialises in contract manufacturing for western drug companies, Mayne said.

Mayne shares closed on Friday at A$3.92, valuing the group's equity at A$2.5 billion ($1.7 billion).




SPOTLIGHT
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..